Plasma levels of nitrites/nitrates in patients with chronic atrial fibrillation are increased after electrical restoration of sinus rhythm

Journal of Interventional Cardiac Electrophysiology

Volumn 7, Issue 2, 2002, Pages 171-176

  Nikitovic, Dragana ^a   Zacharis, Evangelos A ^a   Manios, Emmanuel G ^a   Malliaraki, Nikki E ^a   Kanoupakis, Emmanuel M ^a   Sfiridaki, Katerina I ^a   Skalidis, Emmanuel I ^a   Margioris, Andreas N ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Endothelial function; Internal electrical cardioversion; Nitric oxide; Von Willebrand factor

Indexed keywords

NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEMODYNAMICS; HUMAN; MALE; MECHANICAL STRESS; PRIORITY JOURNAL; SHEAR STRESS; SINUS RHYTHM; TURBULENT FLOW; VASCULAR ENDOTHELIUM;

ATRIAL FIBRILLATION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; ELECTRIC COUNTERSHOCK; FEMALE; HEART RATE; HUMANS; INFANT; MALE; NITRATES; NITRITES; VON WILLEBRAND FACTOR;

EID: 0036816939     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020841906241     Document Type: Article

References (36)

1. Lip GYH, Blann AD. Von Willebrand factor: A marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997;34:255-263.
2. Blann AD, Naqvi T, Waite M, McCollum CN. Von Wille-brand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993;13:1674-1678.
3. Modillo S, Sabatini L, Agricola E, et al. Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic non-rheumatic atrial fibrillation. Int J Cardiol 2000;75:227-232.
4. Drexler H. Endothelial dysfunction: Clinical implications. Prog Cardiovasc Dis 1997;39:287-324.
5. Rubanyi GM, Romero JC, Vanhaute PM. Flow-induced release of endothelium relaxing factor. Am J Physiol 1986;250:H1145-H1149.
6. Buga JM, Gold ME, Fukuto JM, Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991;17:187-193.
7. Hutcheson IR, Griffith TM. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulasatile flow. Am J Physiol 1991;261:H257-H262.
8. Noris M, Morigi M, Donadelli R, et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow condition. Circ Res 1995;76:536-543.
9. Minamino T, Kitakaze M, Sato H, et al. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol 1997;17:3191-3195.
10. Minamino T, Kitakaze M, Sanada S, et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: Role of nitric oxide. Circulation 1998;98:1721-1727.
11. Takahashi N, Ishibashi Y, Shimada T, et al. Atrial fibrillation impairs endothelial function of forearm vessels in humans. J Card Fail 2001;7:45-54.
12. Kanoupakis EM, Manios GE, Mavrakis EH, Kaleboubas DM, Parthenakis IF, Vardas EP. Relation of automatic modulation to reccurence of atrial fibrillation following cardioversion. Am J Cardiol 2000;86:954-958.
13. Verdon CP, Burton BA, Prior RI. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP when the Griess reaction is used to assay for nitrite. Anal Biochem 1995;224:502-508.
14. Lip GYH, Lowe GDO, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: Effects of warfarin therapy. Br Heart J 1995;9:527-533.
15. Moncada S, Palmer R, Higgs E. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-135.
16. Zeballos GA, Berstein RD, Thompson CI, et al. Pharmacodynamics of plasma nitrite/nitrate as indication of nitric oxide formation in conscious dogs. Circulation 1995;91:2982-2988.
17. Kuchan MJ, Frangos JA. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol 1994;266:C628-C636.
18. Marsden PA, Heng HHQ, Sherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993;307:287-293.
19. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhari G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9268.
20. Hogman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet 1993;341:1664-1665.
21. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990;16:377-380.
22. Kawabata A. Evidence that endogenous nitric oxide modulates plasma fibrinogen levels in rat. Br J Pharmacol 1996;117:236-237.
23. Freedman JE, Fabian A, Loscalzo J. Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP. Am J Physiol 1995;268:C520-C526.
24. Li-Saw-Hee FL, Blann AD, Goldsmith I, Lip GYH. Indexes of hypercoagubility measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation. Am J Cardiol 1999;34:255-266.
25. Lip GYH, Lowe GDO. Fibrin D-dimer: A Useful Clinical Marker of Thrombogenesis? 1995;89:205-214.
26. Li-Saw-Hee FL, Blann AD, Gurney D, Lip GYH. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Eur Heart J 2001;22:1741-1747, doi: 10.1053/euhj.2000.2531.
27. Alt E, Ammer R, Schmitt C, et al. A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J 1997;18:1796-804.
28. Pedrinelli R, Giampetro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994;344:14-18.
29. Stehouwer CDA, Nauta JJP, Zeldenrust GP, Hackeng WHL, Donker AJM, den Ottolander GJH. Urinary albumin excretion, cardiovascular disease and endothelial function in non-insulin dependent diabetes mellitus. Lancet 1992;340:319-322.
30. Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-1792.
31. Drexler H. Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc Res 1999;43:572-579.
32. Blann AD, Naqvi T, Waite M, McCollum CN. Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertension 1991;17:187-193.
33. Blann AD, Steele C, McCollum CN. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1997;85:433-438.
34. Greaves M, Pickering C, Knoght G, et al. Changes in factor VIII complex in diabetic ketoacidosis: Evidence of endothelial cell damage? Diabetologia 1987;30:160-166.
35. Zhang X, Hintze TH. Amplodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent. Circulation 1998;97:576-580.
36. Grossmann M, Dobrev P, Himmel HM, Kirch W. Local venous reponse to N-dethylamiodarone in humans. Clin Pharmacol Ther 2000;67:22-31.